An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) will meet on Wednesday to review data on the use of Pfizer Inc and partner BioNTech’s COVID-19 vaccine in adolescents aged 12 to 15.
The vaccine is currently authorized for use in Americans aged 16 and above.
The Advisory Committee on Immunization Practices (ACIP) will vote on the expanded use of the vaccine in the lower age group, the health agency’s meeting agenda showed on Friday, without specifying the exact voting questions.
The drugmakers in April requested U.S. health regulators to extend the vaccine’s use after a clinical trial found it was safe, effective, and produced robust antibody res…
Keep on reading: US CDC panel to vote on using Pfizer COVID-19 shot in adolescents